Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. 1985

F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery

The potency of vecuronium was determined using single bolus dose administrations of 10-50 micrograms kg-1 in 28 patients anaesthetized with thiopentone, nitrous oxide, oxygen and fentanyl. The results were compared with those previously obtained using a cumulative dose technique in a comparable group of 10 patients. The 50% and 95% blocking doses (ED50 and ED95) of vecuronium were found to be 23.1 and 39.6 micrograms kg-1, respectively. These were significantly lower than the 30.5 and 56.7 micrograms kg-1 obtained previously using the cumulative dose technique. We recommend the use of single bolus dose method of determining potency for relatively shorter-acting drugs like vecuronium.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies
D014673 Vecuronium Bromide Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. NC-45,Norcuron,ORG-NC 45,ORG-NC-45,ORG-NC45,Vecuronium,Vecuronium Bromide, Quaternary Ion,Vecuronium Citrate,Vecuronium Hydrobromide,Vecuronium Hydrochloride,Vecuronium Maleate,Vecuronium Phosphate,Bromide, Vecuronium,Citrate, Vecuronium,Hydrobromide, Vecuronium,Hydrochloride, Vecuronium,Maleate, Vecuronium,NC 45,NC45,ORG NC 45,ORG NC45,ORGNC 45,ORGNC45,Phosphate, Vecuronium

Related Publications

F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
October 1982, Anesthesiology,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
January 1985, Acta anaesthesiologica Scandinavica,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
January 1992, Masui. The Japanese journal of anesthesiology,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
January 1987, Revista espanola de anestesiologia y reanimacion,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
July 1988, Clinical pharmacology and therapeutics,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
September 1988, Anesthesiology,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
August 2018, Annals of the Academy of Medicine, Singapore,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
February 1994, Anesthesiology,
F M Gibson, and R K Mirakhur, and R S Clarke, and G G Lavery
June 1995, British journal of anaesthesia,
Copied contents to your clipboard!